139 related articles for article (PubMed ID: 37160228)
1. Templated Reactive Crystallization of Active Pharmaceutical Ingredient in Hydrogel Microparticles Enabling Robust Drug Product Processing.
Manghnani PN; Schenck L; Khan SA; Doyle PS
J Pharm Sci; 2023 Aug; 112(8):2115-2123. PubMed ID: 37160228
[TBL] [Abstract][Full Text] [Related]
2. Hydrogel Microparticle-Templated Anti-Solvent Crystallization of Small-Molecule Drugs.
Bora M; Hsu MN; Khan SA; Doyle PS
Adv Healthc Mater; 2022 Apr; 11(8):e2102252. PubMed ID: 34936230
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic Particle Engineering of Hydrophobic Drug with Eudragit E100─Bridging the Amorphous and Crystalline Gap.
Shikha S; Lee YW; Doyle PS; Khan SA
Mol Pharm; 2022 Nov; 19(11):4345-4356. PubMed ID: 36268657
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
[TBL] [Abstract][Full Text] [Related]
5. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
6. Control of Drug-Excipient Particle Attributes with Droplet Microfluidic-based Extractive Solidification Enables Improved Powder Rheology.
Ng DZL; Nelson AZ; Ward G; Lai D; Doyle PS; Khan SA
Pharm Res; 2022 Feb; 39(2):411-421. PubMed ID: 35119593
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole.
Minecka A; Tarnacka M; Jurkiewicz K; Żakowiecki D; Kamiński K; Kamińska E
Mol Pharm; 2023 Nov; 20(11):5655-5667. PubMed ID: 37756382
[TBL] [Abstract][Full Text] [Related]
8. Modification of the zeta potential of montmorillonite to achieve high active pharmaceutical ingredient nanoparticle loading and stabilization with optimum dissolution properties.
Kumar A; Hodnett BK; Hudson S; Davern P
Colloids Surf B Biointerfaces; 2020 Sep; 193():111120. PubMed ID: 32505995
[TBL] [Abstract][Full Text] [Related]
9. Combining Surface Templating and Confinement for Controlling Pharmaceutical Crystallization.
Banerjee M; Brettmann B
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33092148
[TBL] [Abstract][Full Text] [Related]
10. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
Schver GCRM; Lee PI
Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
[TBL] [Abstract][Full Text] [Related]
11. Salt-kneading: alternative sizing of active pharmaceutical ingredients?
Šimek M; Vyňuchal J; Tomášová L
Pharm Dev Technol; 2016 Dec; 21(8):972-979. PubMed ID: 26365246
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured Valsartan Microparticles with Enhanced Bioavailability Produced by High-Throughput Electrohydrodynamic Room-Temperature Atomization.
Prieto C; Evtoski Z; Pardo-Figuerez M; Hrakovsky J; Lagaron JM
Mol Pharm; 2021 Aug; 18(8):2947-2958. PubMed ID: 34181413
[TBL] [Abstract][Full Text] [Related]
13. A Co-Processed API Approach for a Shear Sensitive Compound Affording Improved Chemical Stability and Streamlined Drug Product Processing.
Schenck L; Neri C; Jia X; Schafer W; Axnanda S; Canfield N; Li F; Shah V
J Pharm Sci; 2021 Sep; 110(9):3238-3245. PubMed ID: 34089710
[TBL] [Abstract][Full Text] [Related]
14. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
Kunnath K; Huang Z; Chen L; Zheng K; Davé R
Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism and crystallization of active pharmaceutical ingredients (APIs).
Lu J; Rohani S
Curr Med Chem; 2009; 16(7):884-905. PubMed ID: 19275600
[TBL] [Abstract][Full Text] [Related]
16. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
[TBL] [Abstract][Full Text] [Related]
17. Current Trends in API Co-Processing: Spherical Crystallization and Co-Precipitation Techniques.
Dhondale MR; Nambiar AG; Singh M; Mali AR; Agrawal AK; Shastri NR; Kumar P; Kumar D
J Pharm Sci; 2023 Aug; 112(8):2010-2028. PubMed ID: 36780986
[TBL] [Abstract][Full Text] [Related]
18. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
[TBL] [Abstract][Full Text] [Related]
19. Microparticle size control and glimepiride microencapsulation using spray congealing technology.
Ilić I; Dreu R; Burjak M; Homar M; Kerc J; Srcic S
Int J Pharm; 2009 Nov; 381(2):176-83. PubMed ID: 19446625
[TBL] [Abstract][Full Text] [Related]
20. The influence of polymeric excipients on desupersaturation profiles of active pharmaceutical ingredients. 1: Polyethylene glycol.
Schneider R; Taspinar L; Ji Y; Sadowski G
Int J Pharm; 2020 May; 582():119317. PubMed ID: 32320721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
